Guidelines for the collection of samples for primaquine / carboxyprimaquine pharmacology analysis
These guidelines aim to standardize the sample collection procedure during clinical studies of primaquine / carboxyprimaquine antimalarial drugs
Publication Version
2.0
Publication Code
CL21
The purpose of this document is to standardize the sample collection procedure during clinical studies of primaquine/carboxyprimaquine antimalarial drugs. Following these recommendations will help you to achieve homogeneous quality in the pre-analytical study phase of studies. This document also includes guidance for the collection, processing, preservation, storage, shipment and safe handling of human origin samples.